跳至主要内容
临床试验/CTRI/2020/01/022726
CTRI/2020/01/022726尚未招募未知

To evaluate the role of Autologous Bone Marrow derived Stem Cell Transplantation for Premature Ovarian Ageing - TAMSCOT

AIIMS0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方
AIIMS

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Age 20-38 years
  • 2.Normal karyotype
  • 3.Adequate uterine cavity either by imaging or hysteroscopically
  • 4.Normal thyroid function tests
  • 5.Diagnosis of premature ovarian failure by FSH > 25IU/l, and/or primary or secondary amenorrhea at least for 4 months
  • 6.Diminished ovarian reserve - AFC < 5, AMH < 1.2ng/ml and/or high FSH ( >8 IU/l)
  • 7.No other cause of female infertility
  • 8.Normal autoimmune work up â?? anti TPO, FBS(R/O IDDM),Complete blood count (R/O ITP, Hemolytic anemia), Anti nuclear antibodies (R/O SLE)

排除标准

  • 1.Past or present evidence of gynecological malignancy
  • 2.Type 1 or II Diabetes Mellitus
  • 3.Presence of anemia ( Hb < 8 g/dl)
  • 4.Contraindications of bone marrow harvesting as per departmental protocol
  • 5.Acquired poor ovarian reserve (Chemotherapy, radiotherapy)
  • 6.Ovarian endometriosis
  • 7.Prior ovarian surgery

研究者

发起方
AIIMS

相似试验